- Asked by: Sue Webber, MSP for Lothian, Scottish Conservative and Unionist Party
-
Date lodged: Wednesday, 17 January 2024
-
Current Status:
Answered by Michael Matheson on 25 January 2024
To ask the Scottish Government, in light of the publication of its Scottish Cancer Strategy for Scotland 2023-2026, how much funding has been committed specifically to prehabilitation, and when it will be allocated to NHS boards.
Answer
Up to £1 million was allocated in 2023 for prehabilitation to NHS boards via the Transforming Cancer Care programme. This has been distributed via the Regional Cancer Networks through regionally agreed prioritisation processes.
£80,000 was allocated to Maggie’s in 2023 to embed their pilot of universal prehabilitation at all eight Maggie’s Centres in Scotland, building on our previous investment to develop this programme of £270,000 in 2021.
- Asked by: Sue Webber, MSP for Lothian, Scottish Conservative and Unionist Party
-
Date lodged: Wednesday, 17 January 2024
-
Current Status:
Answered by Michael Matheson on 25 January 2024
To ask the Scottish Government what is being done to improve access to prehabilitation for less survivable cancers, especially in areas of deprivation.
Answer
Cancer remains a national priority for the NHS and Scottish Government which is why we published a ten year strategy in June 2023, focused on improving cancer survival and providing equitable access to treatment. The strategy and plan take a comprehensive approach to improving patient pathways in cancer from prevention and diagnosis through to treatment and post-treatment care.
The evidence base for prehabilitation specifically for each of the less survivable cancers is currently limited. Work is underway to improve this, particularly with respect to upper gastrointestinal and lung cancers. Learnings from the prehabilitation currently being delivered under the Transforming Cancer Care Programme in association with our findings from the Single Point of Contact and Improving the Cancer Journey initiatives will provide opportunities to target areas of deprivation with early interventions. As such, efforts are being made to exploit these opportunities and progress screening, assessment and timely prehabilitation interventions across Scotland.
- Asked by: Sue Webber, MSP for Lothian, Scottish Conservative and Unionist Party
-
Date lodged: Wednesday, 17 January 2024
-
Current Status:
Answered by Michael Matheson on 25 January 2024
To ask the Scottish Government what assessment it has made regarding whether prehabilitation improves oncological outcomes for patients, in light of its Cancer Action Plan for Scotland 2023-2026, which emphasises the benefits of prehabilitation.
Answer
The evidence for prehabilitation across several areas of oncological care has grown and demonstrates that a multi-modal tired intervention can lead to better functional outcomes and improve other important outcomes associated with cancer treatment including quality of life.
Focus groups with people affected by cancer, evaluations of prehabilitation activities, and evidence collated by others working with people with lived experience of cancer, also tells us that prehabilitation is welcomed by the Scottish population and provides an opportunity for them to engage in their care.
- Asked by: Sue Webber, MSP for Lothian, Scottish Conservative and Unionist Party
-
Date lodged: Wednesday, 17 January 2024
-
Current Status:
Taken in the Chamber on 24 January 2024
To ask the Scottish Government what financial support will be made available to farmers in 2024-25.
Answer
Taken in the Chamber on 24 January 2024
- Asked by: Sue Webber, MSP for Lothian, Scottish Conservative and Unionist Party
-
Date lodged: Friday, 08 December 2023
-
Current Status:
Answered by Jenni Minto on 19 December 2023
To ask the Scottish Government what it is doing to address the gaps in service provision for people with ME, as identified in the report, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Services in Scotland: Findings from an analysis of surveys issued to NHS Boards in Autumn 2022, published in May 2023.
Answer
Our published analysis of health board data on ME/CFS care has established a clearer picture of the variation in service provision around Scotland.
We are considering these findings in identifying areas where there is the potential to further explore or support aspects of service development, and the resource required to do this.
In doing so, we are seeking to ensure that learning from the introduction of models of care for Long COVID is used to benefit the management of other long-term and complex conditions, including ME/CFS, where appropriate.
- Asked by: Sue Webber, MSP for Lothian, Scottish Conservative and Unionist Party
-
Date lodged: Friday, 08 December 2023
-
Current Status:
Answered by Jenni Minto on 19 December 2023
To ask the Scottish Government what it is doing to address the lack of services for children and young people with ME, as highlighted in the report, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Services in Scotland: Findings from an analysis of surveys issued to NHS Boards in Autumn 2022, published in May 2023, in which no services for children and young people were identified in Scotland.
Answer
I refer the member to the answer to question S6W-23717 on 19 December 2023. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers .
- Asked by: Sue Webber, MSP for Lothian, Scottish Conservative and Unionist Party
-
Date lodged: Wednesday, 06 December 2023
-
Current Status:
Taken in the Chamber on 13 December 2023
To ask the Scottish Government whether it is planning any new infrastructure investments in the next financial year in connection with City and Regional Growth Deals.
Answer
Taken in the Chamber on 13 December 2023
- Asked by: Sue Webber, MSP for Lothian, Scottish Conservative and Unionist Party
-
Date lodged: Monday, 20 November 2023
-
Current Status:
Taken in the Chamber on 23 November 2023
To ask the First Minister what work is being done to support the expanding role of the GP surgery.
Answer
Taken in the Chamber on 23 November 2023
- Asked by: Sue Webber, MSP for Lothian, Scottish Conservative and Unionist Party
-
Date lodged: Tuesday, 07 November 2023
-
Current Status:
Answered by Jenni Minto on 14 November 2023
To ask the Scottish Government whether its guidance for people with weakened immune systems regarding the COVID-19 winter booster vaccination has been adapted from previous vaccine programmes to reflect any benefit of repeat vaccines for at-risk groups.
Answer
Information and resources on vaccination are regularly updated to reflect the most recent scientific data and evidence.
The Joint Committee on Vaccination and Immunisation (JCVI) advice for those at risk, including those with a weakened immune system, is that protection from the COVID-19 vaccines is best during the first three months after vaccination. Protection from the COVID-19 vaccines does not stop after three months, but slowly begins to fade. This is why those at risk are invited forward for their booster vaccinations during seasonal programmes. These messages are reflected in our winter vaccine resources. The “Don’t let your protection fade” public marketing campaign also focuses on the importance of revaccination.
Individuals who develop severe immunosuppression may be at high risk of COVID-19 and less able to sustain any protection from previous vaccination or exposure. These individuals can be considered for additional doses of vaccination, outside of seasonal campaigns, based on clinical judgement.
- Asked by: Sue Webber, MSP for Lothian, Scottish Conservative and Unionist Party
-
Date lodged: Tuesday, 07 November 2023
-
Current Status:
Answered by Paul McLennan on 14 November 2023
To ask the Scottish Government what targeted communications are being used to encourage more people with weakened immune systems to get their COVID-19 winter booster vaccination.
Answer
This year’s COVID-19 vaccine marketing and communication plan utilises a number of communication channels to reach those with a weakened immune system, under the “Don’t let your protection fade” campaign. The accompanying marketing toolkit includes a range of assets directed at those who are at higher risk of COVID-19. This toolkit has been shared with Health Boards and stakeholders for them to promote via their own communication channels. The national campaign has also promoted vaccination for those at clinical risk.
All those eligible for winter vaccination have been sent an invitation letter with either a scheduled appointment or instructions on how to book an appointment. Included with this is a leaflet which includes information around why those eligible are being offered a COVID-19 vaccine this winter.
Specific leaflets have been produced for the clinical at risk child and infant groups. These leaflets are designed to help parents/carers make an informed decision about getting their child vaccinated.
All programme patient leaflets can be viewed on NHS Inform.
Winter vaccines briefings for professionals working with people at higher risk are available on the Public Health Scotland website. These explain the importance of the winter vaccines and encourage healthcare professionals to speak to their patients about being vaccinated.